Plant Summary
TCMBank_ID: | TCMBANKHE004641 |
ID: | TCMBANKHE004641 |
植物拉丁名: |
|
药用植物名: | 紫胡 |
TCM_ID_id: | 1663 |
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN000001 | saikosaponin a | 20736-09-8; Saikosaponin A; beta-D-Galactopyranoside, (3beta,4alpha,16beta)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl-6-deoxy-3-O-beta-D-glucopyranosyl-; saikosaponin-a; AIDS-211406; AIDS211406; C08975 | C42H68O13 | 780.98 | CC1C(C(C(C(O1)OC2CCC3(C(C2(C)CO)CCC4(C3C=CC56C4(CC(C7(C5CC(CC7)(C)C)CO6)O)C)C)C)O)OC8C(C(C(C(O8)CO)O)O)O)O |
TCMBANKIN008438 | Saikosaponin K | saikosaponin k | C54H88O22 | 1089.3 g/mol | CC1(CCC2(CCC3(C(=C2C1)C=CC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)CO)O)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)O)C)C)C)CO)C |
TCMBANKIN012170 | 4-O-α-D-rhamnopyranoside | ||||
TCMBANKIN019994 | 16α,23,28,30-tetrahydroxyolean-11,13(18)-dien-3β-yl-β-d-glucopyranosyl-(1→3)-β-d-fucopyranoside | ||||
TCMBANKIN037779 | Hydroxysaikosaponin D | ||||
TCMBANKIN038663 | bupleuroside VI | C42H68O14 | 797 | O1[C@](O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C(=O)C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C4([H])[H] )[C@@]4(C([H])([H])O[H])[C@@]([H])(O[H])C5([H])[H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@]7([H])[C@@]3(C([H])([H])O[H])C([H])([H])[H])O[C@]([H])(C([H])([H])[H])[C@]2([H] )O[H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])C([H])([H])O[H] | |
TCMBANKIN038882 | Spinoside A | acetic acid [(3S,4S,5R,6S)-5-acetoxy-6-[[(8R,9R,10S,13R,14S,16R,17R)-17-[(E,1R)-1,5-dihydroxy-1,5-dimethyl-2-oxohex-3-enyl]-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4-hydroxy-3-tetrahydropy; acetic acid [(3S,4S,5R,6S)-5-acetoxy-6-[[(8R,9R,10S,13R,14S,16R,17R)-17-[(E,1R)-1,5-dihydroxy-2-keto-1,5-dimethyl-hex-3-enyl]-2-hydroxy-3-keto-4,4,9,13,14-pentamethyl-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4-hydroxy-tetrahydrop; AC1O3E1M; 119626-74-3; C08809; [(3S,5R,6S)-5-acetyloxy-6-[[(8R,9R,10S,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4-hydroxyoxan-3-yl] acetate; [(3S,4S,5R,6S)-5-acetyloxy-6-[[(8R,9R,10S,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4-hydroxyoxan-3-yl] acetate; [(3S,4S,5R,6S)-5-acetoxy-6-[[(8R,9R,10S,13R,14S,16R,17R)-17-[(E,1R)-1,5-dihydroxy-1,5-dimethyl-2-oxo-hex-3-enyl]-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4-hydroxy-tetrahydropyran-3-yl] ace; spinoside a; [(3S,4S,5R,6S)-5-acetyloxy-6-[[(8R,9R,10S,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxo-hept-4-en-2-yl]-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4-hydroxy-oxan-3-yl] ethanoate | 164.16 | ||
TCMBANKIN039718 | Phenethylalcohol 8-O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside | ||||
TCMBANKIN039822 | bupleuroside iii | C43H72O14 | 799 | CC1C(C(C(C(O1)OC2CCC3(C(C2(C)CO)CCC4(C3C(C=C5C4(CC(C6(C5CC(CC6)(C)C)CO)O)C)OC)C)C)O)OC7C(C(C(C(O7)CO)O)O)O)O | |
TCMBANKIN041172 | isopentenol-1-o-β-d-apiofuranosyl-(1→6)-β-d-glucopyranoside | C16H28O10 | |||
TCMBANKIN042048 | Hydroxysaikosaponin A | 799 g/mol | |||
TCMBANKIN042138 | Phenethylalcohol 8-O-β-D-glucopyranosyl-(1→2)-O-β-D-apiofuranosyl-(1→6)-β-D-glucopyranoside | ||||
TCMBANKIN042683 | bupleuroside XIII | C42H70O14 | 799 | O1[C@](O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[C@@]3([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@]([H])(O[H])C([H])([H])[C@@]([H])(C(=C([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H] )C4([H])[H])[C@@]4(C([H])([H])O[H])[C@@]([H])(O[H])C5([H])[H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@]7([H])[C@@]3(C([H])([H])O[H])C([H])([H])[H])O[C@]([H])(C([H])([H])[H ])[C@]2([H])O[H])([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])C([H])([H])O[H] | |
TCMBANKIN044288 | Bupleuroside IX | 813 | |||
TCMBANKIN045186 | Saikosaponin E | 765 g/mol | |||
TCMBANKIN046120 | malonylsaikosaponin d | C45H70O16 | 867 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2(C)CO)CCC4(C3C=CC56C4(CC(C7(C5CC(CC7)(C)C)CO6)O)C)C)C)O)OC8C(C(C(C(O8)COC(=O)CC(=O)O)O)O)O)O | |
TCMBANKIN047525 | Malonylsaikosaponin A | 867 g/mol | |||
TCMBANKIN049220 | Saikosaponin BK | C48H78O17 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])=C([H])C(=C(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C([H])([H])O[H])[C@@](O[H])([H])C3([H])[H])[C@@]34C([H ])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@@]7([H] )[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[C@@]8([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O8)[C@@]([H])(C([H])([H])O[H])O7)O6 | ||
TCMBANKIN049343 | Saikogenin D | 472.7 | |||
TCMBANKIN060244 | saikosaponin b3 | C42H68O13 | 781 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2(C)CO)CCC4(C3C=CC5=C6CC(CCC6(C(CC54C)O)CO)(C)C)C)C)O)OC7C(C(C(C(O7)CO)O)O)O)O | |
TCMBANKIN060247 | Saikosaponin D | C42H68O13 | 780.98g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2(C)CO)CCC4(C3C=CC56C4(CC(C7(C5CC(CC7)(C)C)CO6)O)C)C)C)O)OC8C(C(C(C(O8)CO)O)O)O)O | |
TCMBANKIN060677 | alpha-spinasteryl-β-d-glucoside | CCC(C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
---|